FDA Requires Added Warnings on ADHD drugs_Sweden’s “Gillberg Affair”
What does the "Gillberg affair" suggest about the integrity of the data underlying the DAMP-ADHD hypothesis?
What does the "Gillberg affair" suggest about the integrity of the data underlying the DAMP-ADHD hypothesis?
“To me one of the miracle of children’s brains is that we don’t see more harm from these treatments.”
Direct to consumer drug advertisements are so successful, they can convince people they're sick and need the advertised drug–
Direct to consumer drug advertisements are so successful, they can convince people they're sick and need the advertised drug–
News headlines in the Boston area report about the death of four year old
Rebecca Riley, the latest child casualty of prescribed psychotropic drugs.
An appalling spectacle is taking place in secret in the U.K. whose stench is reminiscent of the Salem witches trials of 1692!
"the first-ever randomized, placebo-controlled trial for the alleviation of post-traumatic stress disorder (PTSD)" reports: "we found that it really offered patients no benefits of any symptoms." [1]
The lead story in The New York Times on Thanksgiving day (below) acknowledged several facts demonstrating that children are the victims of major medical malpractice:
An eye opening article by Jeanne Lenzer, “NIH Secrets,” in The New Republic (below), should make the new Congress sit up and take notice!
Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
"The amount of legal stimulants used as medication and produced in our country has grown 2,000 percent in the last 15 years."
Dr. E. Jane Costello, a professor of psychiatry and behavioral sciences at Duke University, acknowledges: “The system of diagnosis is still 200 to 300 years behind other branches of medicine.” Psychiatry also fails to be guided by an evidence-based positive benefit / risk assessment of its prescribed treatments.